Business & Industry

The era of "gut feeling" in pharmaceutical portfolio management is ending. This article explores how advanced analytics, machine learning, and predictive modeling are revolutionizing project prioritization. It details the shift to Monte Carlo simulations, integrated data lakes, and AI-driven decision support, enabling companies to objectively rank programs and optimize R&D return on investment.

The traditional reliance on risk-adjusted Net Present Value (rNPV) and peak sales forecasts is failing to capture the true potential of modern pharmaceutical assets, particularly platform technologies. This article introduces holistic valuation frameworks like Real Options Analysis (ROA) and the Platform VISTA model, arguing for a shift toward valuing "strategic fit," "lifecycle potential," and the intangible equity of innovation engines.

Pharmaceutical companies are radically redesigning portfolio strategies to survive a "triple threat" environment of scientific complexity, regulatory upheaval like the IRA, and capital scarcity. This analysis explores the shift from efficiency-driven models to resilience-first frameworks, detailing how leaders are embedding optionality into pipelines, embracing modality agnosticism, and using dynamic resource allocation to thrive amidst volatility.

For a $950 million upfront, Sobi is all set to get rights to pozdeutinurad - oral URAT1 inhibitor that performed pretty well in the Phase II studies. Sobi is taking over Arthrosi Therapeutics, which is California-based, in a move to...

In one of the most prominent developments for the biotech sector, BaseLaunch has officially welcomed Takeda as its new pharmaceutical partner. This collaboration is going to enhance the present partnership with five other leading pharma companies, now totaling six....

The European Council and European Parliament reached a provisional political agreement, on a comprehensive overhaul of the EU pharmaceutical legislation, the first major reform in more than two decades. The agreement establishes a modernized regulatory framework designed to balance...

When we state that lab space happens to be a really exciting possibility, people don't find it surprising. Unfortunately, most laboratories don't have many possibilities to build the kind of place that continues to improve the technological aspect, resolve...